Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

ALTAFLUOR BENOX

BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM

Standard Dose
0.4%;0.25%
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview ALTAFLUOR BENOX is listed in Drugs@FDA under application 208582 (NDA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.25% Sponsor ALTAIRE PHARMS INC Submission history Latest submission status date: 2017-12-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALTAFLUOR BENOX is listed in Drugs@FDA under application 208582 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.25% Sponsor ALTAIRE PHARMS INC Submission history Latest submission status date: 2017-12-14 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.